Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (891-900 of 996) with videos related to

Pageof 100
Sort By:
Molecular Cell|August 9, 2015
A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous RecombinationAnderson T Wang, Taeho Kim, John E Wagner, et al.
Orthopaedic Journal of Sports Medicine|October 20, 2022
Changes in the Cross-Sectional Profile of Treated Anterior Cruciate Ligament Within 2 Years After SurgeryDanilo Menghini, Shankar G Kaushal, Sean W Flannery, et al.
BMJ Open|April 27, 2026
Prospective Respiratory Outcomes from Tracking and Evaluating Community-based TeSting (Project PROTECTS): a community-based, prospective study of acute respiratory infections among adults across the USA - cohort profileMadhura S Rane, Kate Penrose, McKaylee M Robertson, et al.
Diabetes Research and Clinical Practice|August 30, 2000
A national diabetes care and education programme: the Ghana modelA G Amoah, S K Owusu, J W Acheampong, et al.
Journal for Immunotherapy of Cancer|August 3, 2024
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2023
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS studyKeunchil Park, Joshua K Sabari, Eric B Haura, et al.
NPJ Vaccines|May 22, 2021
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaquesMichael K McCracken, Caitlin H Kuklis, Chandrika B Kannadka, et al.
Human Mutation|August 30, 2014
Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genesElizabeth K Flynn, Aparna Kamat, Francis P Lach, et al.
Cell Reports. Medicine|December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART MoleculeAlexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancerD E Gerber, L Horn, M Boyer, et al.
Pageof 100

Showing results (891-900 of 996) with videos related to

Sort By:
Pageof 100
Molecular Cell|August 9, 2015
A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous RecombinationAnderson T Wang, Taeho Kim, John E Wagner, et al.
Orthopaedic Journal of Sports Medicine|October 20, 2022
Changes in the Cross-Sectional Profile of Treated Anterior Cruciate Ligament Within 2 Years After SurgeryDanilo Menghini, Shankar G Kaushal, Sean W Flannery, et al.
BMJ Open|April 27, 2026
Prospective Respiratory Outcomes from Tracking and Evaluating Community-based TeSting (Project PROTECTS): a community-based, prospective study of acute respiratory infections among adults across the USA - cohort profileMadhura S Rane, Kate Penrose, McKaylee M Robertson, et al.
Diabetes Research and Clinical Practice|August 30, 2000
A national diabetes care and education programme: the Ghana modelA G Amoah, S K Owusu, J W Acheampong, et al.
Journal for Immunotherapy of Cancer|August 3, 2024
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2023
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS studyKeunchil Park, Joshua K Sabari, Eric B Haura, et al.
NPJ Vaccines|May 22, 2021
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaquesMichael K McCracken, Caitlin H Kuklis, Chandrika B Kannadka, et al.
Human Mutation|August 30, 2014
Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genesElizabeth K Flynn, Aparna Kamat, Francis P Lach, et al.
Cell Reports. Medicine|December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART MoleculeAlexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancerD E Gerber, L Horn, M Boyer, et al.
Pageof 100